Timed reminders from your doctor combined with patient scheduling prompts can nearly double lung cancer screening completion rates, according to new research that challenges how health systems approach preventive care. A pragmatic randomized clinical trial found that pairing primary care order alerts with patient reminders increased adherence to annual low-dose computed tomography (LDCT) screening by nearly 28 percentage points, moving completion beyond 75%.

Why Do Reminders Work Better Than Education?

The study, conducted by researchers at Kaiser Permanente Washington and published in JAMA Internal Medicine, enrolled 1,837 patients who had normal findings on an initial LDCT scan. Participants were randomly assigned to usual care, health communication alone, stepped reminders alone, or both interventions.

The results revealed a surprising finding: education delivered shortly after the initial screening actually performed worse than no intervention at all. Patients receiving print or video health communication had lower adherence than those who did not receive it, with completion rates of 59.2% versus 63.3%. This counterintuitive result suggests that information alone, especially when delivered months before action is required, may overwhelm patients or feel disconnected from the actual task of scheduling their next scan.

In contrast, the "Stepped Reminders" pathway proved highly effective. This workflow-based intervention began approximately four weeks before screening was due. Primary care clinicians received an alert to order the examination, and patients subsequently received portal messages and mailed reminders directing them to schedule it. Adherence reached 75.5% among patients exposed to Stepped Reminders compared with 47.4% without them.

Who Benefits Most From Reminder-Based Screening?

The study revealed important differences in how various groups responded to the intervention. Current tobacco users derived the greatest absolute benefit from Stepped Reminders. In this group, reminders increased adherence from 41.2% to 73.0%, a gain of 32.3 percentage points. Among former tobacco users, adherence increased from 52.9% to 77.8%, a difference of 24.1 percentage points. This finding suggests that active smokers, who face the highest lung cancer risk, may particularly benefit from structured outreach and scheduling support.

The intervention also performed differently by sex. Adherence among women was 54.4% with the health communication intervention versus 63.4% without it, whereas rates among men were essentially unchanged. These subgroup findings underscore an important lesson: standardized messaging strategies may not work equally well across all patient populations, and health systems may need to tailor their approaches based on sex, smoking status, and other factors.

How to Improve Lung Cancer Screening Adherence in Your Health System

• Implement Stepped Reminders: Coordinate primary care clinician alerts with patient portal messages and mailed scheduling prompts timed to approximately four weeks before screening is due, creating a linked workflow that connects the order to the scheduling action.
• Pair Reminders With Cessation Support: Integrate evidence-based tobacco cessation counseling and pharmacotherapy alongside screening reminders, without making cessation a prerequisite for screening, to support active smokers who face the highest risk.
• Leverage Pharmacy and Population Health Teams: Use medication histories and tobacco-use documentation to identify eligible patients, and capitalize on routine touchpoints like refill encounters and transitions-of-care calls to verify whether annual LDCT has been ordered and scheduled.
• Track Completion in Electronic Health Records: Embed screening reminders and completion tracking into EHR registries, close referral loops, and monitor adherence to convert screening eligibility into the repeated annual screening required to reduce lung cancer mortality.
• Tailor Messaging by Subgroup: Recognize that sex, smoking status, and other demographic factors may influence response to interventions, and consider developing targeted outreach strategies for groups most likely to benefit.

Annual LDCT is recommended by the US Preventive Services Task Force (USPSTF) for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years. The clinical value of this screening is well established. The National Lung Screening Trial reported a 20% relative reduction in lung cancer mortality with LDCT compared with chest radiography. However, that mortality benefit depends entirely on patients returning for repeat screening year after year, not merely completing an initial scan.

The practical message from this trial is that timing and task design matter enormously. A reminder is most actionable when the clinician can place the order and the patient can schedule the scan in the same workflow. Embedding those linked steps into electronic health record registries and tracking completion may allow pharmacy and multidisciplinary teams to convert screening eligibility into the sustained adherence required to reduce lung cancer mortality.

Because this study was conducted within an integrated, predominantly White cohort already engaged in screening, applicability to more diverse or fragmented healthcare settings remains uncertain. However, the core principle is clear: when it comes to preventive screening, the timing and structure of the reminder matter far more than the volume or quality of educational material.